ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Whitehawk Therapeutics, Inc.
1.57
+0.0900
6.08%
成交量:
140.94万
成交额:
222.64万
市值:
7,345.19万
市盈率:
-0.67
高:
1.60
开:
1.52
低:
1.44
收:
1.48
数据加载中...
总览
公司
新闻
公告
Whitehawk Therapeutics, Inc.2024财年实现净利润-63.69百万美元,同比增加3.16%
市场透视
·
03-22
Aadi Bioscience(AADI.US):2024年Q4财报实现营收723.9万美元,前值为632.6万美元,预期值为737万美元;每股收益为-0.67美元,前值为-0.60美元,预期值为-0.34美元。
金融界
·
03-19
Aadi Bioscience Inc 预计每股亏损22美分 - 财报前瞻
路透中文
·
03-17
Aadi Bioscience, Inc.盘中异动 早盘急速下跌6.06%
市场透视
·
03-13
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠: 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠: 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/WHWK/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"WHWK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WHWK\",,,,,undefined,":{"symbol":"WHWK","market":"US","secType":"STK","nameCN":"Whitehawk Therapeutics, Inc.","latestPrice":1.57,"timestamp":1746126222081,"preClose":1.48,"halted":0,"volume":1409432,"delay":0,"floatShares":29262500,"shares":46784618,"eps":-2.356312,"marketStatus":"交易中","change":0.09,"latestTime":"05-01 15:03:51 EDT","open":1.515,"high":1.6,"low":1.44,"amount":2226441.1119632,"amplitude":0.108108,"askPrice":1.58,"askSize":200,"bidPrice":1.57,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-2.356312,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.48,"postHourTrading":{"tag":"盘后","latestPrice":1.5568,"preClose":1.48,"latestTime":"16:13 EDT","volume":199,"amount":302.2,"timestamp":1746044020425},"volumeRatio":37.907615,"impliedVol":2.0497,"impliedVolPercentile":0.8387},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WHWK\",,,,,undefined,":{"symbol":"WHWK","floatShares":29262500,"roa":"-39.96%","roe":"-80.79%","lyrEps":-2.356312,"volumeRatio":37.907615,"shares":46784618,"dividePrice":0,"high":1.6,"amplitude":0.108108,"preClose":1.48,"low":1.44,"week52Low":1.21,"pbRate":"1.40","psRate":"2.83","week52High":3.812,"institutionHeld":0,"latestPrice":1.57,"committee":-0.970443,"eps":-2.356312,"divideRate":0,"volume":1409432,"delay":0,"ttmEps":-2.356312,"open":1.515,"prevYearClose":3.155,"prevWeekClose":1.45,"prevMonthClose":1.48,"prevQuarterClose":1.78,"fiveDayClose":1.51,"twentyDayClose":1.7,"sixtyDayClose":2.73},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"WHWK\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521234705","title":"Whitehawk Therapeutics, Inc.2024财年实现净利润-63.69百万美元,同比增加3.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2521234705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521234705?lang=zh_cn&edition=fundamental","pubTime":"2025-03-22 00:00","pubTimestamp":1742572846,"startTime":"0","endTime":"0","summary":"3月22日,Whitehawk Therapeutics, Inc.公布财报,公告显示公司2024财年净利润为-63.69百万美元,同比增加3.16%;其中营业收入为25.98百万美元,同比增加6.69%,每股基本收益为-2.36美元。从资产负债表来看,Whitehawk Therapeutics, Inc.总负债17.84百万美元,其中短期债务268000.00美元,资产负债比为3.95,流动比率为3.60。机构评级:截至2025年3月22日,当前有1家机构对Whitehawk Therapeutics, Inc.目标价做出预测,其中目标均价为2.00美元,其中最低目标价为2.00美元,最高目标价为2.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250322000053a69f1be9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250322000053a69f1be9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","WHWK"],"gpt_icon":0},{"id":"2520521509","title":"Aadi Bioscience(AADI.US):2024年Q4财报实现营收723.9万美元,前值为632.6万美元,预期值为737万美元;每股收益为-0.67美元,前值为-0.60美元,预期值为-0.34美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2520521509","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520521509?lang=zh_cn&edition=fundamental","pubTime":"2025-03-19 07:23","pubTimestamp":1742340209,"startTime":"0","endTime":"0","summary":"Aadi Bioscience(AADI.US):2024年Q4财报实现营收723.9万美元,前值为632.6万美元,预期值为737万美元;每股收益为-0.67美元,前值为-0.60美元,预期值为-0.34美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/19072348847757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AADI","WHWK"],"gpt_icon":0},{"id":"2520926525","title":"Aadi Bioscience Inc 预计每股亏损22美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2520926525","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520926525?lang=zh_cn&edition=fundamental","pubTime":"2025-03-17 20:45","pubTimestamp":1742215551,"startTime":"0","endTime":"0","summary":"Aadi Bioscience Inc 预计每股亏损22美分 - 财报前瞻Aadi Bioscience Inc AADI.OQ AADI.O将于3月19日发布截至2024年12月31日的季度财报,预计该公司的季度收入将有所增长。LSEG分析师对Aadi Bioscience Inc的平均预期是每股亏损22美分。华尔街对 Aadi Bioscience Inc 的 12 个月目标价中位数为 3.00 美元,高于上一次收盘价 1.98 美元。3月17日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nL4S3Q00ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","AADI"],"gpt_icon":0},{"id":"2519855124","title":"Aadi Bioscience, Inc.盘中异动 早盘急速下跌6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2519855124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519855124?lang=zh_cn&edition=fundamental","pubTime":"2025-03-13 23:15","pubTimestamp":1741878932,"startTime":"0","endTime":"0","summary":"北京时间2025年03月13日23时15分,Aadi Bioscience, Inc.股票出现波动,股价大幅下挫6.06%。Aadi Bioscience, Inc.股票所在的生物技术行业中,整体跌幅为0.20%。其相关个股中,Apollomics Inc C/Wts 01/04/2028 、Meiragtx Holdings Plc、Exicure, Inc.涨幅较大,Transcode Therapeutics, Inc.、Cervomed Inc.、Cero Therapeutics Holdings, Inc.较为活跃,换手率分别为1216.90%、601.59%、170.84%,振幅较大的相关个股有Tc Biopharm Plc C/Wts 10/02/2028 、Aspire Biopharma Holdings, Inc.、Cervomed Inc.,振幅分别为37.89%、30.03%、29.01%。Aadi Bioscience, Inc.公司简介:Aadi Bioscience Inc 是一家临床阶段的生物制药公司,为基因定义的癌症开发精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031323153298a668c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031323153298a668c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WHWK","BK4139","AADI"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WHWK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-19","symbol":"WHWK","fiscalQuarterEnding":"2024/12","expectedEps":-0.3,"name":null,"time":"盘前","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-06","symbol":"WHWK","fiscalQuarterEnding":"2024/09","expectedEps":-0.46,"name":null,"time":"盘前","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2024-08-07","symbol":"WHWK","fiscalQuarterEnding":"2024/06","expectedEps":-0.71,"name":null,"time":"盘前","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-0.54},{"market":"US","date":"2024-05-08","symbol":"WHWK","fiscalQuarterEnding":"2024/03","expectedEps":-0.66,"name":null,"time":"盘前","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2024-03-13","symbol":"WHWK","fiscalQuarterEnding":"2023/12","expectedEps":-0.67,"name":null,"time":"盘前","type":"earning","dateTimestamp":1710302400000,"reportTimeType":"pre","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WHWK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WHWK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1744776000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/WHWK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"WHWK","date":"2025-04-30","current":-1.079798,"percent":0.642857,"low":-1.256091,"twenty":-1.212018,"median":-1.131217,"eighty":-0.763132,"high":-0.688831,"avg":-1.04063,"sd":0.20077,"marketCap":68773388},"quantilePoints":[{"date":"2025-03-21","current":-0.758488,"twenty":-0.777063,"median":-0.770098,"eighty":-0.763132,"marketCap":48308888},{"date":"2025-03-28","current":-0.735269,"twenty":-0.778611,"median":-0.758488,"eighty":-0.745331,"marketCap":46830044},{"date":"2025-04-04","current":-1.204672,"twenty":-1.122401,"median":-0.762358,"eighty":-0.739913,"marketCap":76726773},{"date":"2025-04-11","current":-1.189981,"twenty":-1.212018,"median":-0.793317,"eighty":-0.745331,"marketCap":75791081},{"date":"2025-04-17","current":-1.131217,"twenty":-1.219363,"median":-1.160599,"eighty":-0.754619,"marketCap":72048311},{"date":"2025-04-25","current":-1.10918,"twenty":-1.212018,"median":-1.134889,"eighty":-0.758488,"marketCap":70644773},{"date":"2025-04-30","current":-1.079798,"twenty":-1.212018,"median":-1.131217,"eighty":-0.763132,"marketCap":68773388}],"updateTime":1746126231036}}}